4,6-Dimethylbenzofuran-2-carboxylic acid, 95%, 1g

(1,2-Dihydroacenaphthylen-5-yl)boronic acid, 95.0%, 25g

(R)-4-Hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 95.0%, 500g

2-(tert-Butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid, 98.0%, 25g

4-benzoyl-8-tert-butyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

1-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)ETHANOL, 97%, 5g

3-bromo-2-chloro-4-methyl-1,5-naphthyridine, 95.0%, 500mg

CYCLOBUTANAMINE, 3-(3-FLUORO-4-METHOXYPHENOXY)-, HCL (1:1), TRANS-, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(3,5-dimethylisoxazol-4-yl)phenyl)propanoic acid, 97%, 1g

2-Phenyl-1-ethylboronic acid, 96.0%, 5g

6-Chlorobenzo[d]oxazol-2-amine, 95.0%, 1g

Flacons de réaction Multi® SafeSeal LowBinding, 1,5 ml, incolore, 1000 pièce(s)

3-([1,1'-Biphenyl]-4-yl)propiolic acid, 95%, 250mg